ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingHans‐Joachim Schmoll, Andrés Cervantes, Eric Van Cutsem et al.|Annals of Oncology|2012Cited by 1.5k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upMichel Ducreux, Dirk Arnold, Caroline Caramella et al.|Annals of Oncology|2015Cited by 1.3k
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upFlorian Lordick, Dirk Arnold, C. Mariette et al.|Annals of Oncology|2016Cited by 1.1k
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trialsDirk Arnold, Fortunato Ciardiello|Annals of Oncology|2017Cited by 829
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trialClaus Rödel, Torsten Liersch, Ullrich Graeven et al.|The Lancet Oncology|2015Cited by 723